✦ LIBER ✦

Perception of healthcare providers versus patient reported incidence of chemotherapy-induced nausea and vomiting after the addition of NK-1 receptor antagonists

✍ Scribed by Margarita Majem; Ma Estela Moreno; Núria Calvo; Anna Feliu; Javier Pérez; Ma Antonia Mangues; Agustí Barnadas

Publisher: Springer-Verlag
Year: 2010
Tongue: English
Weight: 224 KB
Volume: 19
Category: Article
ISSN: 0941-4355
DOI: 10.1007/s00520-010-1042-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Potential role of the NK1receptor antago

Potential role of the NK1receptor antagonists in chemotherapy-induced nausea and vomiting

✍ Paul J. Hesketh 📂 Article 📅 2001 🏛 Springer-Verlag 🌐 English ⚖ 64 KB

Phase 2 trial results with the novel neu

Phase 2 trial results with the novel neurokinin-1 receptor antagonist casopitant in combination with ondansetron and dexamethasone for the prevention of chemotherapy-induced nausea and vomiting in cancer patients receiving moderately emetogenic chemotherapy

✍ Wichit Arpornwirat; Istvan Albert; Vincent L. Hansen; Jeremey Levin; Rajesh R. B 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 172 KB 👁 1 views

Addition of the neurokinin 1 receptor an

Addition of the neurokinin 1 receptor antagonist aprepitant to standard antiemetic therapy improves control of chemotherapy-induced nausea and vomiting : Results from a randomized, double-blind, placebo-controlled trial in Latin America

✍ Sergio Poli-Bigelli; Jose Rodrigues-Pereira; Alexandra D. Carides; Guoguang Juli 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB 👁 1 views